首页|期刊导航|中国临床药学杂志|基于加权TOPSIS法的注射用福沙匹坦双葡甲胺药物利用评价

基于加权TOPSIS法的注射用福沙匹坦双葡甲胺药物利用评价OA

Drug use evaluation of fosaprepitant dimeglumine for injection based on the weighted TOPSIS method

中文摘要英文摘要

目的 建立注射用福沙匹坦双葡甲胺的药物利用评价(DUE)标准,并采用加权优劣解距离(TOPSIS)法评价该药物的使用合理性.方法 以药品说明书为基础,参考相关指南、专家共识及循证医学证据,制定注射用福沙匹坦双葡甲胺DUE标准.随机抽取2023年6月至2024年6月使用注射用福沙匹坦双葡甲胺的病历300份,采用加权TOPSIS法对该药物的合理性进行评价.结果 在注射用福沙匹坦双葡甲胺DUE标准中,11个二级指标按相对权重系数进行排名,前3位依次是适应证、给药剂量和给药疗程.300份病历中用药方案与最优方案接近程度(Ci)≥ 0.8(合理)的病历有134份(占44.67%);0.6≤Ci<0.8(基本合理)的病历有15份(占5.00%),Ci<0.6(不合理)的病历有151份(占50.33%).不合理用药主要表现为不符合适应证用药、用药疗程过长、给药时机不适宜和联合用药不规范等方面.结论 基于加权TOPSIS法的注射用福沙匹坦双葡甲胺DUE方法可综合多个评价指标,客观全面地反映药物利用情况.我院注射用福沙匹坦双葡甲胺的临床应用中存在较多不合理现象,应针对性地进行管理以促进合理用药.

AIM To establish the drug use evaluation(DUE)criteria for fosaprepitant dimeglumine for injection,and evaluate its clinical utilization using the weighted technique for order preference by similarity to ideal solution(TOPSIS)method.METHODS DUE criteria were developed based on the package insert and evidence-based medical evidence.The weighted TOPSIS method was applied to assess the rationality of 300 randomly selected medical records involving fosaprepitant dimeglumine for injection at our hospital from June 2023 to June 2024.RESULTS The top 3 weights in the 11 secondary indicators of DUE criteria for fosaprepitant dimeglumine for injection were indications,dosage,and duration of treatment.Among the 300 cases,134(44.67%)showed a closeness index(Ci)≥ 0.8(rational),15(5.00%)had 0.6 ≤ Ci<0.8(marginally rational),and 151(50.33%)exhibited Ci<0.6(irrational).The main issues of irrational use included off-label indications,prolonged treatment duration,inappropriate timing of administration,and nonstandard combination therapies.CONCLUSION The weighted TOPSIS-based DUE method comprehensively evaluates multiple indicators and objectively reflects the utilization of fosaprepitant dimeglumine for injection.Significant irrational use is identified in our hospital,highlighting the necessity for enhanced management to ensure appropriate medication use.

上官琰;冯嘉丽;朱倩;王斌;付文焕

复旦大学附属华山医院药剂科,上海 200030上海健康医学院药学院,上海 201318复旦大学附属华山医院药剂科,上海 200030复旦大学附属华山医院药剂科,上海 200030复旦大学附属华山医院药剂科,上海 200030

医药卫生

注射用福沙匹坦双葡甲胺药物利用评价加权优劣解距离法合理用药

fosaprepitant dimeglumine for injectiondrug use evaluationweighted technique for order preference by similarity to ideal solution methodappropriate medication use

《中国临床药学杂志》 2026 (8)

723-728,6

10.19577/j.1007-4406.2026.08.009

评论